Current position:Home >Product >
4,7-dimethoxy-N-[(2S)-1-oxidanylidene-1-[4-(phenylmethyl)piperazin-1-yl]propan-2-yl]-1H-indole-2-carboxamide
4,7-dimethoxy-N-[(2S)-1-oxidanylidene-1-[4-(phenylmethyl)piperazin-1-yl]propan-2-yl]-1H-indole-2-carboxamide
|
|
Canonical SMILES:
CC(C(=O)N1CCN(CC1)CC2=CC=CC=C2)NC(=O)C3=CC4=C(C=CC(=C4N3)OC)OC
Isomeric SMILES
C[C@@H](C(=O)N1CCN(CC1)CC2=CC=CC=C2)NC(=O)C3=CC4=C(C=CC(=C4N3)OC)OC
InChI
InChI=1S/C25H30N4O4/c1-17(25(31)29-13-11-28(12-14-29)16-18-7-5-4-6-8-18)26-24(30)20-15-19-21(32-2)9-10-22(33-3)23(19)27-20/h4-10,15,17,27H,11-14,16H2,1-3H3,(H,26,30)/t17-/m0/s1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 7-methoxy-4-methyl-6-[3-oxidanylidene-3-[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]propyl]chromen-2-one
- N-[2-[[(2S)-1-ethylpyrrolidin-1-ium-2-yl]methyl]-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]-2,2-dimethyl-propanamide
- 1-(4-methylsulfonylpiperazin-1-yl)-4-[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]butane-1,4-dione
- N-[2,4-bis(oxidanylidene)-1H-pyrimidin-5-yl]-2-(4-methylpiperazin-1-yl)-2-oxidanylidene-ethanamide
- 1-(3-chloranyl-2-morpholin-4-yl-[1,4]benzodioxino[3,2-b]pyridin-4-yl)pyrrolidine-2,5-dione
- 2-(2-fluoranyl-6-methoxy-phenyl)-4-methyl-N-[4-(morpholin-4-ylmethyl)phenyl]-1,3-thiazole-5-carboxamide
- 2-methyl-N-[2-(2,2,6,6-tetramethylpiperidin-1-ium-4-yl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]propanamide
- [(2S)-1-[2-(dimethylazaniumyl)ethyl]-4,5-bis(oxidanylidene)-2-thiophen-2-yl-pyrrolidin-3-ylidene]-(2,4-dimethylpyrimidin-5-yl)methanolate
- 2-methyl-N-[2-(2,2,6,6-tetramethylpiperidin-4-yl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]propanamide
- oxidanyl-[(5-oxidanylidene-8H-[1,3]thiazolo[3,2-a]pyrimidin-4-ium-7-yl)methyl]phosphinate

